1-Benzyl-1-phenylhydrazine hydrochloride

CAS: 5705-15-7

Ref. 3D-FAA70515

Produktinformation

• Name: 1-Benzyl-1-phenylhydrazine hydrochloride
• Synonyme: 1-Benzyl-1-Phenylhydrazine, 1-Benzyl-1-Phenylhydrazine Hydrochloride (1:1), 1-Benzyl-1-phenylhydrazine hydrochloride (VAN), 2-Benzyl-2-phenylhydrazinium chloride, 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}-3-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-3H-spiro[benzo[h]quinazoline-5,1'-cyclopentan]-4(6H)-one, Hydrazine, 1-benzyl-1-phenyl-, hydrochloride, Hydrazine, 1-benzyl-1-phenyl-, monohydrochloride, Hydrazine, 1-benzyl-1-phenyl-, monohydrochloride (8CI), Hydrazine, 1-phenyl-1-(phenylmethyl)-, hydrochloride (1:1), Hydrazine, 1-phenyl-1-(phenylmethyl)-, monohydrochloride, N-Benzyl-N-phenylhydrazinium(1+) chloride, N-Phenyl-N-benzylhydrazine hydrochloride, Nsc 5716, Usaf Ek-1666, alpha-Benzyl-alpha-phenylhydrazine hydrochloride, α-Benzyl-α-phenylhydrazine hydrochloride

Beschreibung

1-Benzyl-1-phenylhydrazine hydrochloride is a selective androgen receptor modulator that binds to the prostate response element (RARE) in the promoter region of prostate cancer cells. It is used for the treatment of prostatic hyperplasia and benign prostatic hypertrophy. 1-Benzyl-1-phenylhydrazine hydrochloride has been shown to reduce the symptoms of urinary obstruction and to slow the progression of prostate cancer cells in vitro. It also has side effect profiles that are similar to those of nonsteroidal anti-inflammatory drugs, such as gastrointestinal upset and diarrhea.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 234.72 g/mol
• Formel: C₁₃H₁₅ClN₂
• Reinheit: Min. 95%